ADVANCED WOUND MANAGEMENT

DURAFIBER◊Ag PRO Wound Dressing with Antimicrobial Silver and Strengthening Cellulose Fibre

Helps protect wounds for progressive healing with effective fluid management1-8 and a sustained antimicrobial action.9

DURAFIBER-Ag-PRO-CURL-HERO-2000x2000px

Progressive wound healing

Chronic wounds are an ever-growing problem that represent a major social and financial burden,10 with 15-30% remaining unresolved after a year.11,12 Infection is among the most frequent factors associated with stalled wound healing,10 often with subtle signs and symptoms (such as increased exudate) that might not be immediately recognised as infection.13

Help put your patients back on the path to wound health by helping to protect the progression to healing with DURAFIBER Ag PRO Dressing: indicated for deep wounds and high levels of exudate, offering an optimal environment created by a cohesive gel and sustained antimicrobial activity.1,4-7,9

 

Identifying wound infection

Use our structure clinical pathway to help identify the signs and symptoms of infection.

Identify signs and symptoms of infection using a clinical pathway
DURAFIBER-AG-PRO-WEBSITE-OVERVIEW-IMAGE

Product Features


How DURAFIBER Ag PRO Dressings work

Reference material

Medical Education

No results.

Disclaimers

*Based on in vitro data

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Citations
  1. SFM (2022). Clinical Evaluation Report, Internal Report, SN0025.
  2. SFM (2023). Observational Study Report, Internal Report, SN0037.
  3. Smith + Nephew (2024). Internal Report, CSD.AWM.24.035.
  4. SFM (2020). IOV (Traceability) Matrix, Internal Report, SN0003.
  5. SFM (2020). Design Inputs, Internal Report, SN0013.
  6. SFM (2022). Design Verification Report, Internal Report, SN0015.
  7. SFM (2020). Design Validation Report, Internal Report, SN0017.
  8. SFM (2020). Wound Healing Study Miami University, Internal Report, SN0028.
  9. SFM (2020). Silver Release Data, Internal Report, SN0029.
  10. Probst S, et al. J Wound Management, 2022;23(3 Sup1):S1-S33.
  11. Lindholm C, et al. International wound journal. 2016; 13 Suppl 2(Suppl 2), 5–15.
  12. Guest J, et al. BMJ Open. 2020; 10.
  13. International Wound Infection, Institute (IWII) Wounds International. 2022.
  14. Smith+Nephew (2024). Internal Report CSD.AWM.24.038.
  15. SFM (2021). Usability Report, Internal Report, SN0001.
  16. Smith+Nephew (2024). Internal Report CSD.AWM.24.034.
  17. SFM (2020). Antimicrobial Stability Results Summary, Internal Report, SN0030.
  18. SFM (2020). Cytotoxicity MTS Report. Internal Report, SN0026.

Title

Text

Explore